These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26768146)

  • 21. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
    Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
    EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
    Shin ES; Ann SH; Balbir Singh G; Lim KH; Kleber FX; Koo BK
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):193-200. PubMed ID: 26423017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Instantaneous wave-free ratio-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
    Chung JH; Shin ES; Her AY; Lee JM; Doh JH; Nam CW; Koo BK
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):179-185. PubMed ID: 31598811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients - results from the BELLO (balloon elution and late loss optimization) trial.
    Giannini F; Latib A; Jabbour RJ; Costopoulos C; Chieffo A; Carlino M; Montorfano M; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A
    Cardiovasc Revasc Med; 2017; 18(1):4-9. PubMed ID: 28011243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis First-in-Man (PEPPER) trial.
    Hehrlein C; Dietz U; Kubica J; Jørgensen E; Hoffmann E; Naber C; Lesiak M; Schneider H; Wiemer M; Tölg R; Richardt G
    Cardiovasc Revasc Med; 2012; 13(5):260-4. PubMed ID: 22867706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.
    Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R;
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial.
    Xu B; Gao R; Wang J; Yang Y; Chen S; Liu B; Chen F; Li Z; Han Y; Fu G; Zhao Y; Ge J;
    JACC Cardiovasc Interv; 2014 Feb; 7(2):204-211. PubMed ID: 24556098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choice of stenting strategy in true coronary artery bifurcation lesions.
    Lin QF; Luo YK; Lin CG; Peng YF; Zhen XC; Chen LL
    Coron Artery Dis; 2010 Sep; 21(6):345-51. PubMed ID: 20613498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
    Wöhrle J; Werner GS
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of Favorable Angiographic Outcomes After Drug-Coated Balloon Use for de novo Small Vessel Coronary Disease (DCB-ONLY).
    Kang WC; Park SM; Jang AY; Oh PC; Shin ES; Yu CW; Oh SJ; Kim YH; Won H; Lee SR; Lee SY; Hong YJ; Lee SY; Kim BO; Kim SW;
    Angiology; 2021 Nov; 72(10):986-993. PubMed ID: 33982603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late clinical outcomes for SeQuent please paclitaxel-coated balloons in PCI of instent restenosis and de novo lesions: A single-center, real world registry.
    Hee L; Terluk A; Thomas L; Hopkins A; Juergens CP; Lo S; French JK; Mussap CJ
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):375-382. PubMed ID: 27113534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: the CASTOR-Bifurcation registry.
    Sgueglia GA; Burzotta F; Trani C; Todaro D; Talarico GP; Niccoli G; Porto I; Leone AM; Coluccia V; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):503-9. PubMed ID: 20602477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of paclitaxel-coated balloon angioplasty in patients with drug-eluting stent restenosis.
    Dorenkamp M; Boldt J; Leber AW; Sohns C; Roser M; Boldt LH; Haverkamp W; Bonaventura K
    Clin Cardiol; 2013 Jul; 36(7):407-13. PubMed ID: 23595957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first.
    Gutiérrez-Chico JL; van Geuns RJ; Koch KT; Koolen JJ; Duckers H; Regar E; Serruys PW
    EuroIntervention; 2011 Oct; 7(6):711-22. PubMed ID: 21986329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions.
    Généreux P; Kumsars I; Lesiak M; Kini A; Fontos G; Slagboom T; Ungi I; Metzger DC; Wykrzykowska JJ; Stella PR; Bartorelli AL; Fearon WF; Lefèvre T; Feldman RL; LaSalle L; Francese DP; Onuma Y; Grundeken MJ; Garcia-Garcia HM; Laak LL; Cutlip DE; Kaplan AV; Serruys PW; Leon MB
    J Am Coll Cardiol; 2015 Feb; 65(6):533-43. PubMed ID: 25677311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis.
    Nijhoff F; Stella PR; Troost MS; Belkacemi A; Nathoe HM; Voskuil M; Samim M; Doevendans PA; Agostoni P
    Clin Res Cardiol; 2016 May; 105(5):401-11. PubMed ID: 26541146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 12-month intravascular ultrasound observations from BiOSS® first-in-man studies.
    Gil RJ; Bil J; Costa RA; Gil KE; Vassiliev D
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1339-1347. PubMed ID: 27314841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.
    Scheller B; Clever YP; Kelsch B; Hehrlein C; Bocksch W; Rutsch W; Haghi D; Dietz U; Speck U; Böhm M; Cremers B
    JACC Cardiovasc Interv; 2012 Mar; 5(3):323-30. PubMed ID: 22440499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug eluting stenting in bifurcation coronary lesions long-term results applying a systematic treatment strategy.
    Assali AR; Vaknin-Assa H; Lev E; Teplitsky I; Dvir D; Brosh D; Bental T; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):615-22. PubMed ID: 22162218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.